Pushing the envelope—nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation
Crossref DOI link: https://doi.org/10.1038/bmt.2015.61
Published Online: 2015-05-18
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pingali, S R
Champlin, R E
Text and Data Mining valid from 2015-05-18
Version of Record valid from 2015-05-18
Article History
Received: 16 November 2014
Accepted: 17 November 2014
First Online: 18 May 2015
Competing interests
: Dr Champlin has had research grant funding from Otsuka, Sanofi and Celgene Corporations.